Combined hyperlipidemia

Known as: Combined hyperlipidaemia, Multiple-type hyperlipoproteinemia 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2016
012319862016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
OBJECTIVE This study evaluated the effect of a atorvastatin-fenofibrate combination on lipid profile, in comparison to each drug… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2002
2002
BACKGROUND Combined hyperlipidemia (CH) is an increasingly prevalent risk factor for premature heart disease, and its treatment… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Combined hyperlipidemia (CHL) is characterized by a concomitant elevation of plasma levels of triglyceride-rich, very low density… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1998
1998
BACKGROUND Hypertriglyceridaemia is a common metabolic disorder frequently found in patients with coronary heart disease… (More)
Is this relevant?
1997
1997
OBJECTIVE The objective of this study was to evaluate the effects of daily dietary supplementation with 1.25 g or 2.5 g of… (More)
Is this relevant?
1997
1997
This 24-week, randomized, open-label multicenter study evaluated the efficacy and safety of atorvastatin compared with… (More)
Is this relevant?
1996
1996
Elevated plasma cholesteryl ester transfer protein (CETP) mass is characteristic of combined hyperlipidaemia (CHL), an… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein… (More)
Is this relevant?
1992
1992
We have previously reported decreased production rates of the major apolipoprotein B (apoB)-containing lipoproteins, very-low… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
We investigated the metabolism of very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?